PI3K/Akt in platelet integrin signaling and implications in thrombosis

Advances in Biological Regulation

Volumn 59, Issue , 2015, Pages 36-52

  Guidetti, Gianni F ^a   Canobbio, Ilaria ^a   Torti, Mauro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adhesion; Aggregation; Integrins; Platelets; Thrombus formation

Indexed keywords

INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL; GENETICS; HUMAN; METABOLISM; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; HUMANS; INTEGRINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; THROMBOSIS;

EID: 84942552736     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2015.06.001     Document Type: Review

References (131)

1. Andre P., Delaney S.M., LaRocca T., Vincent D., DeGuzman F., Jurek M., et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003, 112:398-406.
2. Aslan J.E., McCarty O.J. Rho GTPases in platelet function. J Thromb Haemost 2013, 11:35-46.
3. Backer J.M. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J 2008, 410:1-17.
4. Badimon L., Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 2014, 276:618-632.
5. Badolia R., Manne B.K., Dangelmaier C., Chernoff J., Kunapuli S.P. Gq-mediated Akt translocation to the membrane: a novel PIP3-independent mechanism in platelets. Blood 2015, 125:175-184.
6. Barczyk M., Carracedo S., Gullberg D. Integrins Cell Tissue Res 2010, 339:269-280.
7. Barry F.A., Gibbins J.M. Protein kinase B is regulated in platelets by the collagen receptor glycoprotein VI. J Biol Chem 2002, 277:12874-12878.
8. Bennett J.S. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005, 115:3363-3369.
9. Bernardi B., Guidetti G.F., Campus F., Crittenden J.R., Graybiel A.M., Balduini C., et al. The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 2006, 107:2728-2735.
10. Bird J.E., Smith P.L., Bostwick J.S., Shipkova P., Schumacher W.A. Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-beta inhibitor in mice. Thromb Res 2011, 127:560-564.
11. Blair T.A., Moore S.F., Williams C.M., Poole A.W., Vanhaesebroeck B., Hers I. Phosphoinositide 3-kinases p110alpha and p110beta have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming. Arterioscler Thromb Vasc Biol 2014, 34:1681-1688.
12. Broos K., Feys H.B., De Meyer S.F., Vanhoorelbeke K., Deckmyn H. Platelets at work in primary hemostasis. Blood Rev 2011, 25:155-167.
13. Buitrago L., Langdon W.Y., Sanjay A., Kunapuli S.P. Tyrosine phosphorylated c-Cbl regulates platelet functional responses mediated by outside-in signaling. Blood 2011, 118:5631-5640.
14. Burke J.E., Williams R.L. Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS). Adv Biol Regul 2013, 53:97-110.
15. Burke J.E., Williams R.L. Synergy in activating class I PI3Ks. Trends Biochem Sci 2015, 40:88-100.
16. Campa C.C., Franco I., Hirsch E. PI3K-C2alpha: one enzyme for two products coupling vesicle trafficking and signal transduction. FEBS Lett 2015, 589:1552-1558.
17. Canobbio I., Balduini C., Torti M. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004, 16:1329-1344.
18. Canobbio I., Stefanini L., Cipolla L., Ciraolo E., Gruppi C., Balduini C., et al. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood 2009, 114:2193-2196.
19. Chang J.C., Chang H.H., Lin C.T., Lo S.J. The integrin alpha6beta1 modulation of PI3K and Cdc42 activities induces dynamic filopodium formation in human platelets. J Biomed Sci 2005, 12:881-898.
20. Chen H., Kahn M.L. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol 2003, 23:4764-4777.
21. Chen J., De S., Damron D.S., Chen W.S., Hay N., Byzova T.V. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004, 104:1703-1710.
22. Chen X., Zhang Y., Wang Y., Li D., Zhang L., Wang K., et al. PDK1 regulates platelet activation and arterial thrombosis. Blood 2013, 121:3718-3726.
23. Chin Y.R., Toker A. Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin. Cell Adh Migr 2011, 5:211-214.
24. Cipolla L., Consonni A., Guidetti G., Canobbio I., Okigaki M., Falasca M., et al. The proline-rich tyrosine kinase Pyk2 regulates platelet integrin alphaIIbbeta3 outside-in signaling. J Thromb Haemost 2013, 11:345-356.
25. Ciraolo E., Iezzi M., Marone R., Marengo S., Curcio C., Costa C., et al. Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 2008, 1:ra3.
26. Consonni A., Cipolla L., Guidetti G., Canobbio I., Ciraolo E., Hirsch E., et al. Role and regulation of phosphatidylinositol 3-kinase beta in platelet integrin alpha2beta1 signaling. Blood 2012, 119:847-856.
27. Cosemans J.M., Angelillo-Scherrer A., Mattheij N.J., Heemskerk J.W. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 2013, 99:342-352.
28. Cosemans J.M., Munnix I.C., Wetzker R., Heller R., Jackson S.P., Heemskerk J.W. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 2006, 108:3045-3052.
29. Crittenden J.R., Bergmeier W., Zhang Y., Piffath C.L., Liang Y., Wagner D.D., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10:982-986.
30. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997, 91:231-241.
31. Dbouk H.A., Vadas O., Shymanets A., Burke J.E., Salamon R.S., Khalil B.D., et al. G protein-coupled receptor-mediated activation of p110beta by Gbetagamma is required for cellular transformation and invasiveness. Sci Signal 2012, 5:ra89.
32. Eisenreich A., Rauch U. PI3K inhibitors in cardiovascular disease. Cardiovasc Ther 2011, 29:29-36.
33. Estevez B., Shen B., Du X. Targeting integrin and integrin signaling in treating thrombosis. Arterioscler Thromb Vasc Biol 2015, 35:24-29.
34. Falasca M., Maffucci T. Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 2012, 443:587-601.
35. Folts J. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Circulation 1991, 83:IV3-14.
36. Fox J.E. Transmembrane signaling across the platelet integrin glycoprotein IIb-IIIa. Ann N Y Acad Sci 1994, 714:75-87.
37. Fritsch R., de Krijger I., Fritsch K., George R., Reason B., Kumar M.S., et al. RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell 2013, 153:1050-1063.
38. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
39. Garcia A., Kim S., Bhavaraju K., Schoenwaelder S.M., Kunapuli S.P. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. Biochem J 2010, 429:369-377.
40. Ghigo A., Morello F., Perino A., Hirsch E. Therapeutic applications of PI3K inhibitors in cardiovascular diseases. Future Med Chem 2013, 5:479-492.
41. Gilio K., Munnix I.C., Mangin P., Cosemans J.M., Feijge M.A., van der Meijden P.E., et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem 2009, 284:33750-33762.
42. Giordanetto F., Wallberg A., Ghosal S., Iliefski T., Cassel J., Yuan Z.Q., et al. Discovery of phosphoinositide 3-kinases (PI3K) p110beta isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyri midin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance. Bioorg Med Chem Lett 2012, 22:6671-6676.
43. Gratacap M.P., Guillermet-Guibert J., Martin V., Chicanne G., Tronchere H., Gaits-Iacovoni F., et al. Regulation and roles of PI3Kbeta, a major actor in platelet signaling and functions. Adv Enzyme Regul 2011, 51:106-116.
44. Gratacap M.P., Payrastre B., Viala C., Mauco G., Plantavid M., Chap H. Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem 1998, 273:24314-24321.
45. Guidetti G., Bertoni A., Viola M., Tira E., Balduini C., Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 2002, 100:1707-1714.
46. Guidetti G.F., Torti M. The small GTPase Rap1b: a bidirectional regulator of platelet adhesion receptors. J Signal Transduct 2012, 2012:412089.
47. Guinebault C., Payrastre B., Racaud-Sultan C., Mazarguil H., Breton M., Mauco G., et al. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol 1995, 129:831-842.
48. Hers I. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood 2007, 110:4243-4252.
49. Hirsch E., Bosco O., Tropel P., Laffargue M., Calvez R., Altruda F., et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 2001, 15:2019-2021.
50. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000, 287:1049-1053.
51. Holtkotter O., Nieswandt B., Smyth N., Muller W., Hafner M., Schulte V., et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002, 277:10789-10794.
52. Holy E.W., Jakob P., Eickner T., Camici G.G., Beer J.H., Akhmedov A., et al. PI3K/p110alpha inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. Eur Heart J 2014, 35:808-820.
53. Hongu T., Kanaho Y. Activation machinery of the small GTPase Arf6. Adv Biol Regul 2014, 54:59-66.
54. Jaber N., Dou Z., Chen J.S., Catanzaro J., Jiang Y.P., Ballou L.M., et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci U S A 2012, 109:2003-2008.
55. Jackson S.P. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med 2011, 17:1423-1436.
56. Jackson S.P., Nesbitt W.S., Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 2003, 1:1602-1612.
57. Jackson S.P., Nesbitt W.S., Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009, 7(Suppl. 1):17-20.
58. Jackson S.P., Schoenwaelder S.M., Goncalves I., Nesbitt W.S., Yap C.L., Wright C.E., et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005, 11:507-514.
59. Jean S., Kiger A.A. Classes of phosphoinositide 3-kinases at a glance. J Cell Sci 2014, 127:923-928.
60. Jung S.M., Moroi M. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change. Eur J Biochem 2001, 268:3513-3522.
61. Kasirer-Friede A., Cozzi M.R., Mazzucato M., De Marco L., Ruggeri Z.M., Shattil S.J. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 2004, 103:3403-3411.
62. Kauffenstein G., Bergmeier W., Eckly A., Ohlmann P., Leon C., Cazenave J.P., et al. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin-a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 2001, 505:281-290.
63. Kim S., Garcia A., Jackson S.P., Kunapuli S.P. Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform. Blood 2007, 110:4206-4213.
64. Kim S., Mangin P., Dangelmaier C., Lillian R., Jackson S.P., Daniel J.L., et al. Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets. J Biol Chem 2009, 284:33763-33772.
65. Kovacsovics T.J., Bachelot C., Toker A., Vlahos C.J., Duckworth B., Cantley L.C., et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 1995, 270:11358-11366.
66. Kroner C., Eybrechts K., Akkerman J.W. Dual regulation of platelet protein kinase B. J Biol Chem 2000, 275:27790-27798.
67. Lagrue A.H., Francischetti I.M., Guimaraes J.A., Jandrot-Perrus M. Phosphatidylinositol 3'-kinase and tyrosine-phosphatase activation positively modulate Convulxin-induced platelet activation. Comparison with collagen. FEBS Lett 1999, 448:95-100.
68. Larson M.K., Chen H., Kahn M.L., Taylor A.M., Fabre J.E., Mortensen R.M., et al. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 2003, 101:1409-1415.
69. Lauener R.W., Stevens C.M., Sayed M.R., Salari H., Duronio V. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin. Biochim Biophys Acta 1999, 1452:197-208.
70. Laurent P.A., Severin S., Gratacap M.P., Payrastre B., Class I.P.I. 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1. Adv Biol Regul 2014, 54:162-174.
71. Laurent P.A., Severin S., Hechler B., Vanhaesebroeck B., Payrastre B., Gratacap M.P. Platelet PI3Kbeta and GSK3 regulate thrombus stability at a high shear rate. Blood 2015, 125:881-888.
72. Lova P., Paganini S., Hirsch E., Barberis L., Wymann M., Sinigaglia F., et al. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem 2003, 278:131-138.
73. Lova P., Paganini S., Sinigaglia F., Balduini C., Torti M.A. Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 2002, 277:12009-12015.
74. Manganaro D., Consonni A., Guidetti G.F., Canobbio I., Visconte C., Kim S., et al. Activation of phosphatidylinositol 3-kinase beta by the platelet collagen receptors integrin alpha2beta1 and GPVI: the role of Pyk2 and c-Cbl. Biochim Biophys Acta 2015, 1850:1879-1888.
75. Marjoram R.J., Voss B., Pan Y., Dickeson S.K., Zutter M.M., Hamm H.E., et al. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen. J Biol Chem 2009, 284:34640-34647.
76. Martin V., Guillermet-Guibert J., Chicanne G., Cabou C., Jandrot-Perrus M., Plantavid M., et al. Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 2010, 115:2008-2013.
77. Moore S.F., Hunter R.W., Hers I. mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 phosphorylation is not required for Akt1 activity in human platelets [corrected]. J Biol Chem 2011, 286:24553-24560.
78. Moore S.F., van den Bosch M.T., Hunter R.W., Sakamoto K., Poole A.W., Hers I. Dual regulation of glycogen synthase kinase 3 (GSK3)alpha/beta by protein kinase C (PKC)alpha and Akt promotes thrombin-mediated integrin alphaIIbbeta3 activation and granule secretion in platelets. J Biol Chem 2013, 288:3918-3928.
79. Moroi A.J., Watson S.P. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3alpha/beta. J Thromb Haemost 2015, 13:1139-1150.
80. Motani A.S., Anggard E.E., Ferns G.A. Recombinant insulin-like growth factor-1 modulates aggregation in human platelets via extracellular calcium. Life Sci 1996, 58:PL269-274.
81. Mountford J.K., Petitjean C., Putra H.W., McCafferty J.A., Setiabakti N.M., Lee H., et al. The class II PI 3-kinase, PI3KC2alpha, links platelet internal membrane structure to shear-dependent adhesive function. Nat Commun 2015, 6:6535.
82. Nieswandt B., Watson S.P. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003, 102:449-461.
83. Nylander S., Kull B., Bjorkman J.A., Ulvinge J.C., Oakes N., Emanuelsson B.M., et al. Human target validation of phosphoinositide 3-kinase (PI3K)beta: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kbeta inhibitor. J Thromb Haemost 2012, 10:2127-2136.
84. O'Brien K.A., Gartner T.K., Hay N., Du X. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3beta. Arterioscler Thromb Vasc Biol 2012, 32:2232-2240.
85. O'Brien K.A., Stojanovic-Terpo A., Hay N., Du X. An important role for Akt3 in platelet activation and thrombosis. Blood 2011, 118:4215-4223.
86. Patrucco E., Notte A., Barberis L., Selvetella G., Maffei A., Brancaccio M., et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004, 118:375-387.
87. Pula G., Poole A.W. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1. Platelets 2008, 19:199-210.
88. Rabie T., Varga-Szabo D., Bender M., Pozgaj R., Lanza F., Saito T., et al. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 2007, 110:529-535.
89. Remijn J.A., Wu Y.P., Jeninga E.H., IJ M.J., van Willigen G., de Groot P.G., et al. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol 2002, 22:686-691.
90. Resendiz J.C., Kroll M.H., Lassila R. Protease-activated receptor-induced Akt activation-regulation and possible function. J Thromb Haemost 2007, 5:2484-2493.
91. Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001, 3:1009-1013.
92. Ruggeri Z.M. Platelet adhesion under flow. Microcirculation 2009, 16:58-83.
93. Ruggeri Z.M., Dent J.A., Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999, 94:172-178.
94. Saci A., Rendu F., Bachelot-Loza C. Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk. Biochem J 2000, 3(351 Pt):669-676.
95. Schaff M., Receveur N., Bourdon C., Wurtz V., Denis C.V., Orend G., et al. Novel function of tenascin-C, a matrix protein relevant to atherosclerosis, in platelet recruitment and activation under flow. Arterioscler Thromb Vasc Biol 2011, 31:117-124.
96. Schoenwaelder S.M., Ono A., Sturgeon S., Chan S.M., Mangin P., Maxwell M.J., et al. Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets. J Biol Chem 2007, 282:28648-28658.
97. Schoolmeester A., Vanhoorelbeke K., Katsutani S., Depraetere H., Feys H.B., Heemskerk J.M., et al. Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood 2004, 104:390-396.
98. Senis Y.A., Atkinson B.T., Pearce A.C., Wonerow P., Auger J.M., Okkenhaug K., et al. Role of the p110delta PI 3-kinase in integrin and ITAM receptor signalling in platelets. Platelets 2005, 16:191-202.
99. Senis Y.A., Mazharian A., Mori J. Src family kinases: at the forefront of platelet activation. Blood 2014, 124:2013-2024.
100. Shattil S.J. The beta3 integrin cytoplasmic tail: protein scaffold and control freak. J Thromb Haemost 2009, 7(Suppl. 1):210-213.
101. Shattil S.J., Newman P.J. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004, 104:1606-1615.
102. Shen B., Delaney M.K., Du X. Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction. Curr Opin Cell Biol 2012, 24:600-606.
103. Signorello M.G., Leoncini G. Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: the role of phosphatidylinositol 3 kinase/AKT pathway. Biochimie 2014, 105:182-191.
104. Smyth S.S., Woulfe D.S., Weitz J.I., Gachet C., Conley P.B., Goodman S.G., et al. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol 2009, 29:449-457.
105. Stefanini L., Bergmeier W. CalDAG-GEFI and platelet activation. Platelets 2010, 21:239-243.
106. Stefanini L., Paul D.S., Robledo R.F., Chan E.R., Getz T.M., Campbell R.A., et al. RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest 2015, 125:1419-1432.
107. Stefanini L., Roden R.C., Bergmeier W. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood 2009, 114:2506-2514.
108. Stegner D., Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med Berl 2011, 89:109-121.
109. Stritt S., Wolf K., Lorenz V., Vogtle T., Gupta S., Bosl M.R., et al. Rap1-GTP-interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice. Blood 2015, 125:219-222.
110. Sultan C., Plantavid M., Bachelot C., Grondin P., Breton M., Mauco G., et al. Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. J Biol Chem 1991, 266:23554-23557.
111. Toker A., Marmiroli S. Signaling specificity in the Akt pathway in biology and disease. Adv Biol Regul 2014, 55:28-38.
112. Torti M. PI3Kbeta inhibition: all that glitters is not gold. Blood 2015, 125:750-751.
113. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007, 9:316-323.
114. Vanhaesebroeck B., Guillermet-Guibert J., Graupera M., Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010, 11:329-341.
115. Vanhaesebroeck B., Leevers S.J., Panayotou G., Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 1997, 22:267-272.
116. Vanhaesebroeck B., Stephens L., Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012, 13:195-203.
117. Wang Z., Holly S.P., Larson M.K., Liu J., Yuan W., Chrzanowska-Wodnicka M., et al. Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation. J Thromb Haemost 2009, 7:693-700.
118. Watson S.P., Auger J.M., McCarty O.J., Pearce A.C. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005, 3:1752-1762.
119. Weyrich A., Cipollone F., Mezzetti A., Zimmerman G. Platelets in atherothrombosis: new and evolving roles. Curr Pharm Des 2007, 13:1685-1691.
120. Wonerow P., Pearce A.C., Vaux D.J., Watson S.P. A critical role for phospholipase Cgamma2 in alphaIIbbeta3-mediated platelet spreading. J Biol Chem 2003, 278:37520-37529.
121. Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M., Brass L.F. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004, 113:441-450.
122. Woulfe D., Jiang H., Mortensen R., Yang J., Brass L.F. Activation of Rap1B by G(i) family members in platelets. J Biol Chem 2002, 277:23382-23390.
123. Woulfe D.S. Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost 2005, 3:2193-2200.
124. Woulfe D.S. Akt signaling in platelets and thrombosis. Expert Rev Hematol 2010, 3:81-91.
125. Wu Y.P., Vink T., Schiphorst M., van Zanten G.H., Ijsseldijk M.J., de Groot P.G., et al. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol 2000, 20:1661-1667.
126. Yi W., Li Q., Shen J., Ren L., Liu X., Wang Q., et al. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161. PLoS One 2014, 9:e102394.
127. Yin H., Stojanovic A., Hay N., Du X. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 2008, 111:658-665.
128. Zhang J., Rittenhouse S.E. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of Wortmannin on phosphoinositide 3-kinase and aggregation. Biochem Biophys Res Commun 1995, 211:484-490.
129. Zhang J., Vanhaesebroeck B., Rittenhouse S.E. Human platelets contain p110delta phosphoinositide 3-kinase. Biochem Biophys Res Commun 2002, 296:178-181.
130. Zhang J., Zhang J., Shattil S.J., Cunningham M.C., Rittenhouse S.E. Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin. J Biol Chem 1996, 271:6265-6272.
131. Zhu Q.S., Rosenblatt K., Huang K.L., Lahat G., Brobey R., Bolshakov S., et al. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene 2011, 30:457-470.